Meticulous Research® has released a report titled “Protein Expression Market by System (Mammalian [CHO, HEK 293], Non-mammalian [Bacterial, Insect, Yeast]), Offering (Kits & Reagents, Vectors, Competent Cells, Services), Application (Industrial, Therapeutic, Research), and End User – Global Forecast to 2030,” projecting the protein expression market to reach $5 billion by 2030, with a CAGR of 7.6%. This growth is driven by factors such as the expanding biopharmaceutical market, increasing demand for recombinant proteins, rising cell-based research, a growing prevalence of chronic diseases, advancements in molecular and cellular technologies to enhance bioproduction efficiency, and increasing government funding for life sciences. Emerging economies and the rise of point-of-care (POC) technology also present significant growth opportunities. However, challenges such as the high costs of protein-based research and a shortage of skilled professionals, along with complexities in laboratory transformation parameters, could hinder market expansion. The report segments the market by system type, product and services, application, end user, and geography, analyzing competitors at regional and country levels. It is expected that by 2024, the mammalian cell expression system segment will hold the largest share of the market, due to its acceptance for closely resembling human physiology, which minimizes post-translational modification efforts and reduces cross-contamination risks, in addition to supporting therapeutic protein production and offering low-cost, user-friendly solutions.
